Literature DB >> 8189453

Inappropriate breast secretions of possible bacterial etiology in the parous nonpuerperal female.

J J Freeman1, R H Altieri, A H Freeman, T Kuo, F Sardinha, C C Buckingham, J J Sklar, K Dyroff, A Floyd.   

Abstract

This article presents two cases of spontaneous green breast secretions of parous nonpuerperal patients. To understand the nature of these secretions, bacterial evaluations and subsequent treatment were undertaken. Case 1 culture and sensitivity studies from breast secretions were commenced within 24 hours yielding an isolate identified as Staphylococcus epidermidis, with sensitivity to cephalothin, erythromycin, and tetracycline but resistant to penicillin. Cephalothin, 500 mg four times a day for 10 days, followed by erythromycin 100 mg twice a day for 10 days and doxycycline 100 mg twice a day for 10 days, did not alter the breast secretions. Four weeks later, ciprofloxacin HCI 500 mg twice a day for 6 weeks caused a 50% decrement in breast secretion at 4 weeks but increased clinical depression. At 6 weeks, no evidence of breast secretions persisted. Mental depression decreased within 2 weeks postciprofloxacin treatment. In Case 2, a total of 35 minutes elapsed between sample collection and initiation of culture and sensitivity studies. Moraxella osloensis was identified and found sensitive to ampicillin and tetracycline but resistant to trimethoprim. Ampicillin 500 mg four times a day for 10 days and doxycycline 100 mg twice a day by mouth for 10 days were administered at 2-week intervals with no effect on breast discharge. After 4 weeks of treatment failure, ciprofloxacin HCI 500 mg twice a day for 6 weeks caused a 50% decrease in discharge at 2 weeks and total elimination at 6 weeks. Lethargy during treatment ceased with termination of therapy. These results support the importance of bacterial evaluation of breast secretions with subsequent antibiotic therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8189453      PMCID: PMC2568182     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  26 in total

1.  Concentrations of ciprofloxacin in serum and prostatic tissue in patients undergoing transurethral resection.

Authors:  M Grabe; A Forsgren; T Björk
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

2.  The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

Review 3.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

4.  Penetration of ciprofloxacin into bronchial secretions.

Authors:  E Bergogne-Bérézin; G Berthelot; P Even; M Stern; P Reynaud
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

5.  A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.

Authors:  L Shrire; J Saunders; R Traynor; H J Koornhof
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

Review 6.  Norfloxacin: a quinoline antibiotic.

Authors:  D A Marble; J A Bosso
Journal:  Drug Intell Clin Pharm       Date:  1986-04

Review 7.  Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.

Authors:  M LeBel
Journal:  Pharmacotherapy       Date:  1988       Impact factor: 4.705

8.  Ciprofloxacin concentrations in tonsils following a single intravenous infusion.

Authors:  N Falser; A Dalhoff; H Weuta
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

9.  Ciprofloxacin concentrations in bone and muscle after oral dosing.

Authors:  I W Fong; W H Ledbetter; A C Vandenbroucke; M Simbul; V Rahm
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

10.  Concentration of ciprofloxacin in human prostatic tissue after oral administration.

Authors:  M Dan; J Golomb; A Gorea; Z Braf; S A Berger
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.